Oncolytics Biotech buy Raymond James
Start price
04.04.24
/
50%
€1.61
Target price
04.04.25
€2.76
Performance (%)
-
End price
05.04.25
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Oncolytics Biotech | - | - | - |
| iShares Core DAX® | -0.676% | 4.053% | 2.212% |
| iShares Nasdaq 100 | 0.993% | 10.872% | 38.041% |
| iShares Nikkei 225® | 3.279% | 13.468% | 59.003% |
| iShares S&P 500 | 0.621% | 6.195% | 26.154% |
Comments by Raymond_James for this prediction
In the thread Oncolytics Biotech diskutieren
Oncolytics Biotech Inc. (NASDAQ: ONCY) is now covered by analysts at Raymond James. They set an "outperform" rating and a $3.00 price target on the stock.
Ratings data for ONCY provided by MarketBeat
In the thread Trading Oncolytics Biotech
Die von Raymond_James gewählte maximale Laufzeit wurde überschritten